Novavax, Inc. - Common Stock (NQ:NVAX)
Price and Volume
Detailed Quote| Volume | 4,735,632 |
| Open | 7.590 |
| Bid (Size) | 7.500 (4,000) |
| Ask (Size) | 7.550 (100) |
| Prev. Close | 7.720 |
| Today's Range | 7.430 - 7.980 |
| 52wk Range | 6.245 - 13.38 |
| Shares Outstanding | 74,484,166 |
| Dividend Yield | N/A |
Top News
More NewsVia MarketBeat
Performance
52-Week Range
44.2% below 52-week high
7.470
6.2552W Low
13.3852W High
1 Week
11.3% below 1-week high
7.431W Low
8.421W High
Novavax, Inc. - Common Stock (NVAX) traded between $6.25 and $13.38 over the past 52 weeks and last traded at $7.47, 44.2% below its 52-week high. Over the past week it ranged between $7.43 and $8.42.
Past 12 Months
-7.3%
-25.2%
-15.7%
-28.6%
+4.8%
+15.5%
1W
-$0.59
1M
-$2.52
3M
-$1.39
6M
-$2.99
YTD
+$0.34
1Y
+$1.00
NVAX was +15.5% over the past year, -28.6% over six months, +4.8% year to date, -7.3% in the last week.
12 Months vs Market
NVAX
+15.5%
DIA
+4.0%
SPY
+4.7%
QQQ
+3.1%
IWM
+8.9%
Over the past 12 months NVAX returned +15.5% versus DIA (Dow) +4.0%, SPY (S&P 500) +4.7%, QQQ (Nasdaq 100) +3.1% and IWM (Russell 2000) +8.9%.
Volume & Liquidity
0.71× 3-mo avg
Today 4,735,632
3-mo avg 6.7M
1W
4.3M
1M
5.8M
3M
6.7M
6M
5.5M
YTD
5.2M
1Y
5.0M
NVAX most recently traded 4,735,632 shares against a 3-month average daily volume of 6.7M.
More News
Read More
Novavax Q3 Earnings Call Highlights ↗
November 06, 2026
Via MarketBeat
Topics
Earnings
NVAX Q3 2026 deep dive: Sanofi milestone and cost controls shape outlook
November 06, 2026
Via StockStory
Novavax (NVAX) Q3 2026 Earnings Call Transcript ↗
November 05, 2026
Via The Motley Fool
Topics
Earnings
Via StockStory
Novavax (NVAX) reports earnings tomorrow: what to expect
November 03, 2026
Via StockStory
Topics
Artificial Intelligence
3 small-cap stocks walking a fine line
October 23, 2026
Via StockStory
Topics
Supply Chain
3 Reasons NVAX is Risky and 1 Stock to Buy Instead
October 20, 2026
Via StockStory
Topics
Stocks
Via StockStory
3 Overrated Stocks We Approach with Caution
October 02, 2026
Via StockStory
3 Volatile Stocks with Questionable Fundamentals
September 21, 2026
Via StockStory
Novavax Highlights Sanofi, Pfizer Catalysts in Matrix-M Platform Pivot ↗
September 10, 2026
Via MarketBeat
Novavax Highlights Matrix-M Licensing Push, Oncology Ambitions at Cantor Conference ↗
September 10, 2026
Via MarketBeat
3 Russell 2000 Stocks We’re Skeptical Of
September 10, 2026
Via StockStory
3 of Wall Street’s Favorite Stocks with Open Questions
September 09, 2026
Via StockStory
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds
September 03, 2026
Via StockStory
3 Unprofitable Stocks Walking a Fine Line
August 21, 2026
Via StockStory
Novavax (NVAX) Shares Skyrocket, What You Need To Know
August 19, 2026
Via StockStory
Frequently Asked Questions
Is Novavax, Inc. - Common Stock publicly traded?
Yes, Novavax, Inc. - Common Stock is publicly traded.
What exchange does Novavax, Inc. - Common Stock trade on?
Novavax, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Novavax, Inc. - Common Stock?
The ticker symbol for Novavax, Inc. - Common Stock is NVAX on the Nasdaq Stock Market
What is the current price of Novavax, Inc. - Common Stock?
The current price of Novavax, Inc. - Common Stock is 7.470
When was Novavax, Inc. - Common Stock last traded?
The last trade of Novavax, Inc. - Common Stock was at 11/20/26 04:00 PM ET
What is the market capitalization of Novavax, Inc. - Common Stock?
The market capitalization of Novavax, Inc. - Common Stock is 556.40M
How many shares of Novavax, Inc. - Common Stock are outstanding?
Novavax, Inc. - Common Stock has 556M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>